Pulse Scientific Information

Pulse Scientific/ KSL Biomedical KSL Biomedical, Inc., developers of novel diagnostic and therapeutic applications for immunology, oncology, virology, and genomics, announces expansion into Canada with the acquisition of Pulse Scientific, Inc. a diagnostic products manufacturer and distributor of medical, laboratory and research products located in Toronto. With the incorporation of KSL Biomedical Canada, Inc., and the acquisition of Pulse Scientific, KSL extends its international base for product distribution and laboratory sales, positioning the company to merge additional technology, business lines, and acquisition targets in Burlington, the Greater Toronto Area (GTA), and beyond. Pulse Scientific established in 1992, specializes in the manufacturing and distribution of technical microbiology products and controls for clinical, industrial, and pharma customers, as well as in vitro diagnostic (IVD) tests for laboratories and physicians. The company is ISO 13485 certified and licensed by Health Canada, positioning it to distribute medical devices and in vitro diagnostics in Canada, Europe, and many other markets throughout the world. “Our leadership team brings to Canada decades of scientific training and experience in diagnostics and deep relationships with market leaders who can assist in identifying emerging industry opportunities and introducing novel applications to address them. We expect the acquisition to invigorate access to markets for existing Pulse Scientific and KSL Biomedical products, as well as complementary products to be identified by our incoming Canadian business development team,” said Kevin Lawson, President and CEO of KSL Biomedical. Presenting a number of synergistic opportunities, the acquisition allows KSL to add proprietary products and services to its pipeline, including exclusive diagnostics, laboratory products, medical devices, and assays, utilizing proprietary biomarkers and instrumentation.